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1. Introduction 
This chapter provides an introduction to the work by briefly introducing the problem and 
motivation of the thesis and the objectives. The document structure is described in the layout 
section. 
1.1 Problem 
In many countries, Europe in particular, statistical evidence shows a decline in human 
mortality over the 20
th
 century. There is no sign of mortality rates leveling out or 
improvement rates even slowing down in the near future. The continuing decline in 
morality have far reaching consequences for pension funds and for the future 
financing of public health care and the state pension system. Mortality improvements 
have caused life offices to incur losses on the life annuity business. The problem lies 
in the fact that pensioners are living much longer than anticipated. As a result life 
offices are paying out much longer than what was forecasted, and their profit margins 
are being eroded in the process. The insurance industry is therefore bearing the costs 
of unexpected higher longevity. Looking forward, possible changes in lifestyle and 
medical advances are likely to make future improvements to life expectancy very 
unpredictable as well.  
1.2 A possible solution 
The growing mortality concern mentioned above has led actuaries to think differently. 
Actuaries have traditionally been using static and deterministic mortality intensity, 
which is a function of the age only. Here, we are modelling the mortality intensity as a 
dynamic and stochastic process. The advantage of introducing stochastic mortality 
intensity is twofold. Firstly, it gives more realistic life tables, and secondly, it 
quantifies the risk of the insurance companies and pension funds associated with the 
underlying mortality intensity.  
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1.3 Objective 
Several of today‟s dynamic survival models of stochastic type are based on the Perks 
model. Master thesis will study estimation within a more flexible Gompertz-
Makeham framework and compare with results under the other model, namely, Perks. 
The objective of this thesis is to decide as to which model is most suitable for Europe. 
Another objective is to study if there is any correlation in the development between 
different European countries and among genders. 
1.4 Layout 
The layout of this thesis is as follows. We start with chapter 2 (Data) where we 
present the data. Chapter 3 (Dynamic and Survival Modelling) presents the 
fundamental concepts and models which the reader needs to look at in order to follow 
our work. Chapter 4 (Model parameters) look at the parameters estimated for the two 
models. In Chapter 5 (Testing the models) we present the results of our work on the 
historic data and test the two models. Next we have chapter 6 (Forecasting Future 
Mortality Trends) in which we forecast mortality in the future and compare the 
results. Chapter 7 (Economic Consequences) focuses on the financial side of 
improvements in mortality. And finally chapter 8 (Conclusion) where we conclude 
our findings.  
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2. Data 
This chapter presents the data requirements for this thesis. 
 
The data used in this thesis is taken from the Human mortality database (HMD), 
which offers free access to original calculations of death rates and life tables for 
national populations, as well as the raw data used in constructing those tables. It also 
contains life expectancy and exposure data for a long list of countries. The database is 
maintained by the University of California, Berkeley, USA and Max Planck Institute 
for Demographic Research, Germany.  
The data we are using consists of gender specific q(t,x) death rates and the 
corresponding exposure to risk E(t,x) for a range of years t and ages x. More precisely, 
death rates gives the probability of death occurring in calendar year t among people 
aged x and exposure to risk gives the total number of years lived during calendar year 
t by people of age x. Seven main countries of Europe have been used for comparison 
which are: England & Wales, France, East & West Germany, Italy, Russia and Spain. 
There is no combined data available for Germany, instead divided into east and west; 
therefore we are considering each of them as individual countries. The availability of 
the data was different for each country. Some had data starting way back from the 
nineteenth century, while the others had data starting from the mid fifties. The latest 
data also varied from country to country. So for those countries which had enough 
historic data, the starting year for them is considered to be 1950, while the others have 
their original starting year from the database. For England & Wales, the data used for 
estimation is from 1950-2003, 1950-2005 for France, 1956-2004 for East & West 
Germany, 1950-2004 for Italy, 1959-2006 for Russia and 1950-2005 for Spain. The 
data is available for ages 0 to 110+, where the last age is an open-ended interval 
covering age 110 and above.  
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As far as the accuracy of the data is concerned, apart from Russia and Spain, the rest 
have no quality issues. The quality of the data for Russia for 1959-1969 is lower than 
in later years. There is also a growing problem with the quality of population 
estimates at ages 90+ in the second half of the 1990s. It results in underestimation of 
mortality at these ages especially for males. Spain‟s data from 1950-1960 display age 
heaping problems and this might affect our results a bit.  
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3. Dynamic survival modelling 
In this chapter we present the fundamental concept of dynamic survival modelling and 
explain the two models we are testing along with other theoretical elements used throughout 
the thesis.  
3.1 What is dynamic modelling? 
Mortality assumptions have played a central role throughout the whole history of life 
insurance and pension mathematics, whose origins can be traced back to the second 
half of the 17
th
 century. Despite this long history, it was not until the construction of a 
long series of mortality observations that trends in mortality clearly emerged, and 
hence the concept of “dynamic” mortality was achieved, namely at the beginning of 
the 20
th
 century. 
A dynamic model accounts for the element of time where as a static model does not. 
As time is very important when we forecast mortality, actuaries came up with the idea 
of dynamic modelling. Mortality in a dynamic context is assumed to be a function of 
both the age x and the year t. For example, the expected lifetime for a newborn is 
denoted by E0 in a non-dynamic context, but in a dynamic context it is represented by 
E0(t), a function of the calendar year t (namely the year of birth). Similarly, the 
general death rate in a given population can be represented by a function q(t), where t 
denotes the calendar year in which the population is considered. Actuarial 
calculations for pension plans and in life insurance involve the use of mortality 
assumptions expressed as q(t,x), which is the underlying probability that an individual 
aged exactly x at time t will die before time t+1. The period t to t+1 will also be 
referred to as year t. The next section will introduce us with the two dynamic survival 
models which are used in this thesis.  
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3.2 Survival models 
3.2.1 Gompertz-Makeham 
Humans have been trying to understand life and death for as long as they existed. In 
1825, a British actuary, Benjamin Gompertz presented his version of the survival 
probability formula, based on the recognition that human mortality displayed 
exponential patterns for most ages. He found that the probability of dying was high at 
birth but then declined until sexual maturity.  After this it increased at an exponential 
rate. His result is believed to be the most influential parametric mortality model in the 
literature. Some years later, in 1860, Makeham noticed that Gompertz‟s model was 
not adequate for higher ages and amended it in an effort to correct this deficiency. 
This amended model is called the Gompertz-Makeham model and the mortality 
intensity is modeled as follows: 
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Here, t is time in years, x is the age and θ1, θ2 and θ3 are the parameters estimated from 
the maximum likelihood program specifically designed for Gompertz-Makeham 
parameter estimation. This model estimates the death probabilities which will be used 
in all the calculations involving Gompertz-Makeham.   
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3.2.2 Perks 
Following on from Gompertz work, Perks (1932) proposed that instead of using an 
exponential function, the force of mortality was best described by a logistic function 
of age. In this thesis we will restrict ourselves to the following model for the mortality 
curve. This is a special case of what is known as the Perks model. 
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Like the first model, this one also has t, which represents time in year, x representing 
the age, and θ1 and θ2 are the parameters estimated using another maximum likelihood 
program for Perks parameter estimation. Perks model involves two stochastic factors. 
The first affects mortality at all ages in an equal number, whereas the second has an 
effect on morality that is proportional to age. The model will provide the death 
probabilities which are then used throughout the thesis for assessing Perks.  
3.3 Random Walk 
A commonly used model in finance is the random walk. To make forecast of the 
future distribution of θ for both models, we will model θ as random walk with drift:      
                                                    
1
,ˆ ˆit it itit                                             (3.3.1) 
where i=1,2,3 for Gompertz-Makeham and i=1,2 for Perks, t is the calendar year 
e.g.2005...2050, ˆit is the new estimated stochastic parameter, μit is the drift and it  are 
multivariate normally distributed random variables with mean zero and a covariance 
matrix,   
                                                            it ~ ( , )N                                                      (3.3.2) 
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Here   is a 2x2 matrix for Perks and 3x3 for Gompertz-Makeham.  
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4. Model Parameters 
This chapter presents the method used to estimate the parameters of the survival models and 
briefly examines them. 
 
Parameters for our models are estimated using maximum likelihood estimation 
programs which were provided by the supervisor, one program for each model. In 
order to get the desired parameters, the following steps are followed: 
1. Get the required data from HMD database for a specific country and gender. 
2. Adjust the maximum likelihood program according to the requirements. 
3. Run the program and find the estimated parameters. 
These routines were followed for each model, each country and for each gender 
separately. After a lot of hard work and effort, we finally get the estimated parameters 
in a form which can then be used to estimate morality. To give an example of the type 
of parameters we get from these maximum likelihood programs, the following figures 
are plotted: 
 
Fig 4.1: Parameters of the Perks model of female mortality in England & Wales for years 1950-2003. 
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Estimated values for Perks θ1 and θ2 for years 1950-2003 for England & Wales 
female are plotted in the figure 4.1. The downward trend in θ1 reflects general 
improvement in mortality over time at all ages. The increasing trend in θ2 means that 
the curve is getting slightly steeper over time: that is, mortality improvements have 
been greater at lower ages. 
Similarly, figure 4.2 shows the development of three estimated parameters of 
Gompertz-Makeham over 54 years. While the first parameter is age-independent, the 
remaining two are age-dependent. The development of θ2 and θ3 is almost the same as 
we saw for Perks parameters above.  
 
Fig 4.2: Parameters of the Gompertz-Makeham model of female mortality in England & Wales for years 1950-
2003. 
 
Note that the Gompertz-Makeham model depends on three parameters while the Perks 
have two. Another thing to mention here is the range of age. The maximum likelihood 
program is not able to estimate the parameters for all ages. It stops estimation at a 
certain point, but this varies from country to country. Russia has the age range 0-111, 
England & Wales 0-101, France 0-99, East & West Germany 0-98, Italy 0-101 and 
Spain 0-104. 
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5. Testing the models 
This chapter examines each model separately and compare their results. The calculations of 
this chapter revolve around historic data. The idea is to test how the two models work and 
how well each model fits the historic data.   
5.1 Aim 
We are aiming at a detailed investigation of mortality trends over a particular period 
for both genders from age 0 to 111. The intention here is to give a broad picture of the 
main features of mortality and a detailed analysis using the two models. The choice of 
which countries to include in the comparison of trends, is influenced by the 
completeness, reliability and uniformity of the data, but, at the same time, by the 
desire to widen the representation. Period covered by the study varies from country to 
country, but on average we are looking at fifty-three years of data ranging from 1950-
2006 for seven different countries.  
The same procedure will be applied for each model separately, after which the two 
models are compared. Here we have chosen to show the results for East Germany 
only. The other countries will also be reviewed, but in a more generalized manner.  
5.2 Gompertz-Makeham model 
5.2.1 Mortality Curves 
The first thing we are looking at is the mortality curve. We use the maximum 
likelihood program to estimate the three parameters of Gompertz-Makeham for age 0-
111, from year 1956 to 2004. Using equation 3.2.2 and the parameters for each year 
one by one, death probabilities are calculated. Figure 5.2.1 illustrates the death 
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probability of female aged 0-111 for year 1956, 1976, 1996 and 2004. The first figure 
is drawn using the historic data while the second shows the data estimated by 
Gompertz-Makeham model. 
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Fig.5.2.1: Historic and estimated mortality plot for female 
One can see a decline in mortality over the years. The two figures are presented 
together in order to give a picture of the goodness or closeness of our estimation 
compared to historic data. Though the curves are not exactly the same, they are more 
or less similar in nature. Both plots show a decline in mortality over time. Our 
estimated plot seems to have a bit higher death probabilities compared to the historic 
plot at the old ages. Remember that maximum likelihood program for Gompertz-
Makeham estimated parameters till age 98 for East Germany, meaning that we can 
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only compare our estimates with the historic data up to age 98.  The fluctuating data 
in the historic plot after age 100 is bad data and is not considered so important. So it 
does not make much of a difference if we skip data comparison after age 98 as we 
have bad data after this age and also that not many live up to this age.  
The morality curve is unclear for the age group 0-60. It is hard to see the trend at early 
age. But detailed analysis of all the age group is important; therefore the mortality 
curve is divided into four age groups as shown in the figure below: 
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Fig.5.2.2: Gompertz-Makeham female mortality plot divided into four age groups 
From figure 5.1.2 it is very clear that there has been mortality decline in 49 years for 
all age groups. Mortality improvements from 1956 to 1976 can be primarily attributed 
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to improvements in the age-specific death rates for the age group from 0-50, where as 
mortality decline in the years 1976 to 1996 are mainly due to decline in age-specific 
death rates for the age group 51-111.   
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Fig.5.2.3: Historic and estimated mortality plot for male 
Mortality rate for male population is shown in figure 5.2.3. The figure has exactly the 
same type of plots as figure 5.2.1, except that we have changed female to male data. 
As for the case for female, male mortality rate has also declined over the years. This 
can be identified by the colors of the curves where black curve is for year 1956 and 
blue for 2004.  One can see an incredible decrease in mortality in 49 years. Both for 
male and female, the greatest decline has come between years 1976 and 1996. The 
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reason for that might be advances in medicine between these years. Bad data also 
exists for male in the old age and therefore not taken into consideration. Over 
estimation at the old age can also be seen here. We will look more into it later.   
5.2.2 Male and Female comparison 
Next, we are looking at male and female mortality together. It is a well known fact 
that women live longer than men. With that said it would be interesting to see if that 
is really the case for East Germany. It might not be the case for every country, but the 
historic data for East Germany shows that female have a lower mortality rate than 
men. Comparing male and female mortality using Gompertz-Makeham model, we 
come up with the following results: 
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Fig.5.2.4: Male Vs Female mortality plots 
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Figure 5.2.4 compares the mortality rates of male and female for year 1956, 1976, 
1996 and 2004 separately. Red curves indicate male mortality of the given year, while 
black curves indicate female mortality. One can easily notice that the red curves are 
over the black ones in all the four plots shown above, indicating that men have a 
higher mortality rate than women which mean that women live longer than men and 
thus supporting the fact. Though the curves start to cross each other after the age has 
passed 90, it is of less importance as not many live above that age. As mentioned 
earlier, we have bad data at old age and the maximum likelihood program stops 
estimation after age 98. This can be the reason for over estimation at old age and can 
also be the cause of male mortality lower than female mortality.    
5.2.3 Goodness of fit 
Gompertz-Makeham‟s model seems to be working reasonably well for now, but it is 
too early to conclude that the model is good. What we are interested in now is to 
check how good the model fits the historic data. In other words, how well can we 
estimate mortality using our model. Figures 5.2.5 and 5.2.6 below illustrate 
Gompertz-Makeham‟s estimates plotted over the original data. Figure 5.2.5 is a 
female plot for year 1956, 1976, 1996 and 2004, whereas figure 5.2.6 shows a male 
plot for the same years. Plots are in log scale. Here, we are plotting log of q(x) against 
age. For both 1956 and 1976 female, one can see an over-estimation for up to age 40, 
after which the curve fits very well. 1996 female shows an over-estimation by 
Gompertz-Makeham till age 20 and a slight under-estimation around age 40-50. 2004 
female also have similar pattern, over-estimation till age 40 and a slight under 
estimation for age 40-60.  
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Fig.5.2.5: historic Vs estimated log(qtx)  plots for female 
Next, we are looking at male plots. 1956 male plot shows Gompertz-Makeham over 
estimating for young and middle age, but fits well for age 50 and over. Both 1976 and 
1996 plots show a good fit over all, although there is an over estimation till age 20. 
2004 male also has similar pattern with over estimation at the start age, a slight 
fluctuation in the middle, and smooth towards the end. Ignoring the early ages, 
Gompertz-Makeham fits generally very well for the rest of the ages.  
In actuarial context, under estimation is not a very good sign. This can lead to many 
economic problems which we will discuss in the coming chapters. As far as 
Gompertz-Makeham is concerned, we have seen a slight under estimation on a few 
occasions and this will be taken into consideration. 
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Fig.5.2.6: historic Vs estimated log(qtx)  plots for male 
 
5.2.4 Mortality improvement 
Decreasing mortality is a problem world wide for insurance companies and pension 
funds. Next we look at the extent to which mortality is decreasing over the years. 
Here, we are considering three different population percentiles. Calculation is based 
on the following: 
                                  
111
0 1
1
( ) (1 )(1 )...(1 )i i i it t t tx
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P X x q q q 

                              (5.2.1) 
where, qtx is the death probability, x is the age and ε = 20%, 50%, 80%,  is the 
percentile. We are calculating that an X year old will be at least x years old at a given 
time t. Here, i indentifies the age at which this probability equals the percentile.  
Figure 5.2.7 is a mere reflection of our calculation. It is indeed an interesting plot. 
The plot shows three different percentiles of population deaths through years. On the 
left we have a plot for women and on the right for men. The pattern is the same in 
both cases. What we see is an increase in death age per year. 20% of the female 
population died at the age of 63 in 1956, 50% died at 77 and 80% at 85 the same year. 
On the other hand, 20% of the male population died at the age of 55, 50% at 73, and 
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80% died at 82 in 1956. By 2004, 20% of the female population died at the age of 75, 
50% at 85, and 80% at 92. For male population, 20% died at 66, 50 % at 78, and 80% 
at 87.  
We can now look at the amount of increase in death age over the 49 years. For 20% 
population, the increase in death age is 12 years for female and 11 for male. 50% 
population had an increase of 8 years for female and 5 years for male. And finally, 
80% of the population‟s death age increased by 7 years for female and 5 for male.  
This analysis has shown us three important things: firstly, there is mortality 
improvement for both genders. Secondly, men tend to die before women. And finally, 
the mortality of women is improving a bit more than men‟s.    
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Fig.5.2.7: Male and female death population percentile  
 28 
5.3 Perks 
The next model we are looking at is the Perks model. Validation process is the same 
as used for Gompertz-Makeham.  
5.3.1 Mortality Curves 
We have already seen how the historic mortality looks like for East Germany male 
and female and how well Gompertz-Makeham model estimates. Now we are checking 
if Perks estimation is any closer to historic data. Figure 5.3.1 shows two plots, one for 
female and one for male. The mortality curves are produced by first estimating the 
two parameters for Perks using the maximum likelihood estimate program, then using 
these parameters in equation 3.2.3 to get the death probabilities. The plots produced 
by Perks look also good. The declining mortality trend over the years as seen by 
Gompert-Makeham for both the genders can also be seen here. One interesting thing 
to notice is the death probability. While the historic and Gompertz-Makeham‟s 
estimation showed a death probability ranging from 0-1, Perks give us probability 
range from 0-0.7. There is a huge difference in the mortality range among the two 
models. Therefore, it would be interesting to see the results of the two models 
together in order to compare them. The next section will cover the comparison part. 
For now, we will continue to look at Perks estimation only.  
While the Gompertz-Makeham‟s mortality curves looked very similar to historic data, 
Perks plots are a bit different in nature. Though we have seen earlier that mortality is 
decreasing for every year, it is not in case of Perks male plot. Here we see 1976 
mortality greater than for 1956. In general, we see slightly different mortality curves 
produced by Perks, than one we got from Gompertz-Makeham.   
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Fig.5.3.1: Perks estimated mortality plot for female and male 
 
5.3.2 Male and Female comparison 
The next part is to compare the mortality rates of male and female respectively. Figure 
5.3.2 illustrates this. Again, we get similar pattern to the one we found using 
Gompertz-Makeham. Male mortality is above female mortality throughout the curve, 
except for the last few ages which we can be neglected.  
 
 30 
0 20 40 60 80 100
0
.0
0
.2
0
.4
0
.6
Male vs Female
Age
D
e
a
th
 p
ro
b
a
b
ili
ty
female 1956
male 1956
0 20 40 60 80 100
0
.0
0
.2
0
.4
0
.6
Male vs Female
Age
D
e
a
th
 p
ro
b
a
b
ili
ty
female 1976
male 1976
0 20 40 60 80 100
0
.0
0
.2
0
.4
0
.6
Male vs Female
Age
D
e
a
th
 p
ro
b
a
b
ili
ty
female 1996
male 1996
0 20 40 60 80 100
0
.0
0
.2
0
.4
0
.6
Male vs Female
Age
D
e
a
th
 p
ro
b
a
b
ili
ty
female 2004
male 2004
 
Fig.5.3.2: Male Vs Female mortality plots 
At a first glance Perks estimates do not look very promising. As far as goodness of fit 
of Perks model is concerned, the results above tell little about that therefore it is too 
early to say anything about the model.   
5.3.3 Goodness of fit 
The next thing of interest is the goodness of fit. We need to see how well Perks model 
estimates the mortality. As we did for Gompertz-Makeham, we are plotting historic 
data and estimated data together, where the dotted plot is historic data and red line 
represent the estimates. Figure 5.3.3 illustrates the case for female population for year 
1956, 1976, 1996 and 2004. Plots for year 1956 and 1976 are pretty similar. We see 
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an under estimation for the early age group, followed by a slight over estimation in 
the middle age, and under estimation again for the later age group. Plots for 1996 and 
2004 reveal an under estimation till about age 50-60, followed by a good fit. We have 
just looked at four cases. It is hard to see a pattern by looking at just these plots. But 
we do get a slight idea that Perks does not fit very well.   
 
Fig.5.3.3: historic Vs estimated log(qtx)  plots for female 
 
5.3.4 Mortality improvement 
We want to see how Perks model estimates death ages and what do the estimates say 
about increase or decrease in mortality. Figure 5.3.4 reflects our calculation. The plot 
shows three percentiles of population died through years. The pattern is the same in 
both cases. What we see is an increase in death age per year. 20% of the female 
population died at the age of 65 in 1956, 50% died at 77 and 80% at 85 the same year. 
On the other hand, 20% of the male population died at the age of 60, 50% at 73, and 
80% died at 82 in 1956. By 2004, 20% of the female population died at the age of 75, 
50% at 84, and 80% at 92. For male population, 20% died at 66, 50 % at 78, and 80% 
at 87.  
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We can now look at the amount of increase in death age over the 49 years. For 20% 
population, the increase in age is 9 years for female and 6 for male. 50% population 
had an increase of 7 years for female and 5 years for male. And finally, 80% of the 
population‟s death age increased by 7 years for female and 5 for male.  
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 Fig.5.3.4: historic Vs estimated log(tQx)  plots for male 
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5.4 Comparing the two models 
After working on each model separately, we have got a bit of idea of the way the two 
models work and estimate. In this section our aim is to compare the results of the two 
models together. There are two things we are interested in: 
1. Goodness of fit 
2. Estimated change in death age overthe years. 
 
 
Fig.5.4.1: historic Vs estimated log(qtx)  plots for male for both G-M and Perks 
We have seen how the two models fit the historic data. In order to see the similarities 
or differences in their fit, we have plotted them together in figure 5.4.1. Historic data 
is presented with dots, red line shows Gompertz-makeham estimation, while the blue 
line indicates Perks. The four plots are for the male population for year 1956, 1976, 
1996 and 2004. One notices that Gompertz-Makeham starts with an over estimation, 
comes in line and then estimates well all the way. Perks on the other hand starts with 
an under estimation, estimates well in the middle and loses track again right at the 
end.  
After observing the plots of both Gompertz-Makeham and Perks, we can conclude 
that Gompertz-Makeham gives an over estimation for early ages which in our case is 
from age 0 to age 40 but estimates very well the death probability for later ages. This 
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gives us a range of good estimation of about 70 years. Perks on the other hand under 
estimates for the early ages (0-40) and for the later ages (80-111), but works well for 
the middle age group. This gives Perks a range of about 40 years of good estimation. 
From what we have seen, it is clear that Gompertz-Makeham is working better.  
Another thing we need to look at is the difference in the mortality improvements 
estimated by each model. As seen earlier, Gompertz-Makeham estimates a 12 year 
improvement in death age for 20% of the female population in 49 years, compared to 
9 of Perks. For men we see Gompertz-Makeham showing 11 years of improvement, 
whereas Perks showed only 6. For the other two percentiles, the results are closer. But 
overall, Perks estimate less morality improvement than Gompertz-Makeham. This can 
also be verified by looking at the goodness of fit plot for each model where we see 
Perks under estimating on many occasions.  
By looking at East Germany, we can easily say that Gompertz-Makeham fits better to 
the historic data and therefore is a more trust worthy model. Whether it works better 
for the other European countries as well is yet to be found in the next section.    
5.5  A look at other European countries 
This section deals with the remaining six countries. Though we have just shown the 
results for East Germany, the calculations done on the remaining countries also show 
mortality decline over the years. Figure 5.5.1 visualizes the mortality trends for each 
country. Age is considered from 0-90. The plots are for female mortality. Male 
mortality also follows similar trend.  
Apart from Russia, all the other countries experience the same declining mortality 
trend. Russia has had a very strange mortality trend over the past 50 years or so. This 
can be true due to war and all, but there is also a possibility of bad data. Looking 
closely at Russia one can see almost no change in mortality trend over the years. In 
fact, it is fluctuating up and down over the years but still with not much effect. It is 
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hard to believe that on some occasions the mortality is increasing instead of 
decreasing like seen elsewhere in Europe. It would be interesting to see how our 
models deal with Russia‟s data when we introduce forecasting the future in the next 
chapter. 
 
Fig.5.5.1: Historic female mortality trends for Europe 
 
5.5.1 Goodness of fit       
Plots of goodness of fit for female of each country are shown in the figures below. 
Both the models are plotted over the historic data. We found this to be the best way to 
visualize how each model fits to the historic data of each country. This gives us the 
general idea about the way each model works. The plots are of the same nature as we 
have seen earlier.  We have chosen to draw the plots of latest available data and 
picked one random year from the middle. There is no specific reason for it. It does not 
make any difference which year to choose as plot for every year is unique. We are 
showing data for two years for each country in order to get a general idea of how 
these models fit.  
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Starting with Gompertz-Makaham first (red curve), we see a general pattern which 
this model follows. As seen earlier, Gompertz-Makeham over estimates at early ages. 
This is the case for almost every year and for every country we have tested. The age-
group for which the model over estimates is seen to be round about 0-40. It may be 
less or more on few occasions as in case of Spain-1970 or Italy-1970, where it over 
estimate for the range 0-50. In general, we see a good, smooth fitting of the estimates 
for the rest of ages. But there are a few instances where the model under estimate for 
the middle ages from 40-60, like for West Germany-2004, France-2005 or Spain-
2005. Overall, we can conclude that Gompertz-Makaham fits well except from the 
start ages ranging from 0-40.  
Next we look at the green curves which represent Perks estimates. Perks model also 
follows a general pattern. It is not a flexible model as Gompertz-Makeham is; 
therefore we see very bad fit to the historic data. It is hard to see anything about the 
age groups for which the model fits. But one thing is prominent in almost every plot 
we have studied. There is a clear under estimation for the early age, over estimation 
for the middle age, and under estimation again towards the old age. We see a straight 
line going through the historic data, with very little correct estimation. The curve 
bends a little for old age.  The best fit is seen for Italy-2004.  
After looking at all the seven countries, there is no doubt remaining in our minds that 
Gomeprtz-Makeham fit way better than Perks. The reason for that seems to be the 
extra parameter Gompertz-Makeham contains. This makes the model more flexible 
and help capture the bends in mortality curves.  
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5.6 Correlation 
The focus of this section will be on correlation. We are interested in looking at the 
mortality relation between different European countries and among male and female, 
if any.  
Correlation indicates the strength and direction of a linear relationship between two 
random variables. The correlation coefficient ρX,Y between two random variables X 
and Y with expected values μX and μY and standard deviations σX and σY is defined as: 
                               ,
(( )( ))( , )
( ) ( )
X Y
X Y
X Y
E X YCov X Y
Var X Var Y
 

 
 
                       (5.6.1)      
We wanted to check if mortality trend in one country or in one gender had any effect 
on the trend of another country or gender. And if so, what kind of effect? Will there 
be a mortality decline in France if we see mortality decline in Spain? If male 
population experience an improvement in mortality, will the female population of the 
same country also experience it? These are the types of question which can be 
answered with the help of correlation and that was our aim.  But unfortunately, due to 
limited time we were not able to analyze correlation. It would have been interesting to 
see the linear relationships between European countries and genders. It can be a 
useful study for insurance companies which operate throughout Europe.   
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6. Forecasting future mortality trends 
This chapter focuses on forecasting mortality in the future. Survival probabilities and life 
expectancies for the two models are compared. 
 
Time series forecasting is the use of a model to describe the likely outcome of the 
future events based on known past events. In this chapter we are looking at mortality 
in the future. Our aim is to describe future age patterns of mortality on the basis of the 
mortality trends we have experienced in the previous chapter. Using the random walk 
mentioned in chapter 3, we estimate the paramters for our models in order to forecast 
the future mortality trends. From there death probabilties are calculated. The idea is to 
forecast and compare the future mortality of different European countries using the 
two mortality models and compare the results. 
6.1 Forecasting mortality 
We have seen mortality rates have fallen dramatically at all ages for all the countries 
observed, with Russia an exception. Improvement rates have been significantly 
different at different ages. Since rates of improvement have varied over time and have 
been different at different ages, there will be considerable uncertainty in forecasting 
what rates of improvement will be in the future. It would be intersting to see how 
much moratlity will decrease over the coming years.  
6.1.1 Parameter distribution 
The results are based on 1000 independent simulations. The parameters we get are 
stochastic in nature, meaning that every time we simulate we get a new value for 
every parameter. In order to make the parameters more consistent, 1000 simulations 
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have been conducted for every parameter and their mean value is used for further 
calculations. An example of the 1000 simulations per parameter is as follows: 
 
Fig.6.1.1: Perks parameter distributions 
 
Fig.6.1.2: Gompertz-Makeham parameter distributions 
 
Starting with Gompertz-Makeham model first, in order to make forecasts of the future 
distribution of 1 2 3( , , )it t t t    , we will model it  as a three-dimensional random walk 
with drift as mentioned in equation 3.3.1. This will give us the desired parameters for 
our model. This procedure is followed 1000 times for every parameter of every year 
and their mean values are used in order to make our results more consistent. Using 
Gompertz-Makeham‟s survival model, we can then calculate the death probabilities in 
future. We are forecasting morality up to 2050. 
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 Fig 6.1.3: historic and forecasted female mortality 
The figure above shows mortality rates for female of England & Wales. The black 
and read lines show mortality in year in 1950 and 2000, while the other two lines are 
forecasted using Gompertz-Makeham model. Clearly, the mortality is decreasing over 
the years. This was the expected result. The question is how far in the future can we 
estimate moratlity using these models? We are considering till 2050. Further than that 
can be a problem. The reason for that is that our parameter estimation is purely based 
on past experience. In the last fifty years or so, there has been many medical advances 
which led to this major mortality decline. Decrease in infant mortality and decreasing 
deaths at old ages has been the driving force in recent mortality improvements. But 
humans are mortal and will die at one stage. If we forcast using just the the data from 
the past, we will see that at one stage the forecasted mortality rate in the future will be 
almost zero for all ages and that is ofcourse not true. So there are limits to these 
models. We can not forecast for the next hundred years or so as that will give us very 
unrealistic moratity rates.  
We have seen how Gompertz-Makeham model forecasts morality. Now we are 
looking at Perks. The procedure is the same as before. In order to make forecasts of 
the future distribution of 1 2( , )it t t   , this time we will model it  as a two-
dimensional random walk with drift as mentioned in equation 3.3.1. This will give us 
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the desired parameters for our model. And putting these parameters in Perks model, 
death probabilities are calculated. Again we are forecasting up to 2050 because of the 
same reasons. Figure 6.1.4 shows Perks forecasted mortality. Along with it we have 
Gompertz-Makeham‟s forecasted mortality from the previous plot. Both have the 
same forecasted years. This is an easy way to compare the results of the two models 
together. Its clear that Perks also shows a further decrease in mortality over the next 
years.  Up to about the age of 85, both show the same amount of decrease in mortality 
rate for 2020 and 2050, are which Perks (dotted line) decrease further for the old ages. 
The results are as expected. We knew from before that Perks under estimate for old 
ages and that is exactly what we see here.  
  
 
Fig.6.1.4: G-M and Perks  forecasted female mortality 
6.2 Survival probability 
In this section our focus is on forecasting the survival probability. Let X be the length 
of life of an individual. Then the survival probability is as follows: 
                                                  ( | )tPx P X x t X x                                          (6.2.1) 
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This is the likelihood that a person of age x lives at least t years longer. As we have 
calculated qx previously, we can get tPx by using the equation below:  
                  
1 1(1 )t x t x x tp p q                                                (6.2.2) 
Decline in mortality means an automatic improvement in survival probability. We 
expect survival rate to increase over the coming years. To see how the survival rates 
differ for the two models and how much they improve over the years, the following is 
plotted: 
 
   Fig 6.2.1: G-M and Perks  forecasted female survival rate 
Figure 6.2.1 shows the forecasted survival probabilities of new born Italian female for 
Gompertz-Makeham and Perks for year 2010 and 2050. By new born we mean x = 0. 
Full curves are Gompertz-Makeham estimates while the dotted shows Perks 
estimation. Both models estimate an improvement in mortality from 2010 to 2050.  If 
we look at the survival plots for 2010 first, we observe that both models have very 
close estimates. Up to about the age of 65, Perks has a slightly higher estimation of 
the survival probability compared to Gompertz-Makeham‟s, but declines after that. 
This pattern can also be seen for 2050, where Perks is slightly above Gompertz-
Makeham till the age of 75, but declines rapidly after that. As we observed earlier, 
Perks tend to under estimate at older ages. This is exactly what we are seeing here. 
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Another thing to notice is the change in survival rate over the years by the two 
models. Gompertz-Makeham has a greater change.   
6.3 Life Expectancy 
Life expectancy is the average number of years of life remaining at a given age. It is 
also the measure of change when describing the effect of improvements in death rates 
over time and when comparing „the state of mortality‟ in different countries. We are 
interested in seeing the change in life expectancy in the furture for different countries 
and genders. Using the tPx mentioned above (6.2.2), life expectancy can be calculated 
as follows: 
0
( ) t xE X p dt

                                                  (6.3.1)    
This is the general formula for finding the life expectancy of a person aged x. In our 
case x = 0, giving life expectancy at birth.   
6.3.1 Results 
 
    2020         2035         2050     
  GM Perks    GM Perks    GM Perks  
Country M F M F   M F M F   M F M F 
East Germany 
 
76.8   84.4    77.9  
 
84.6   
 
77.6   86.7   79.6  
 
86.4   
 
78.2   88.9   81.3  
 
88.1  
West Germany 
 
79.0   84.7    79.1  
 
83.1   
 
81.1   87.1   81.6  
 
85.7   
 
83.0   89.3   84.1  
 
88.3  
Russia 
 
54.5   73.3    60.6  
 
74.2   
 
45.9   72.9   60.1  
 
74.3   
 
36.5   72.3   59.5  
 
74.2  
England&Wales 
 
79.1   83.2    79.2  
 
82.7   
 
81.2   85.1   81.2  
 
84.4   
 
83.1   86.9   83.3  
 
86.3  
France 
 
79.0   86.5    79.2  
 
85.4   
 
81.0   88.9   81.7  
 
87.4   
 
83.0   91.1   84.1  
 
89.1  
Spain 
 
79.1   85.7    78.1  
 
84.4   
 
80.9   87.3   79.6  
 
86.2   
 
82.6   88.4   80.8  
 
87.7  
Italy 
 
80.3   86.8    80.1  
 
86.5    
 
82.0   89.2   81.7  
 
88.2    
 
83.6   91.5   83.1  
 
89.6  
Table 6.3.1: Forecasted life expectancies of new born male and female 
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Table 6.3.1 contains the forecasted life expectancies of seven countries for both male 
and female in year 2020, 2035 and 2050 for both Gompertz-Makeham and Perks. The 
table will be used to compare the countries, gender and the two models. The estimates 
are for new born and therefore age x = 0 and year t = 1,2,3…111. We can look at East 
Germany first. The expected life for a new born male in 2020 in East Germany is 
estimated to be 76.8 years using Gompertz-Makeham model and 77.9 using Perks. In 
2005, male life expectancy was reported to be 75.7. This means that according to 
Gompertz-Makeham, life expectancy will increase by about a year in the first fifteen 
years, while Perks shows an increase of about two years. Though a small margin, this 
one year difference between these two models can have a substantial impact 
economically which we will discuss in the next chapter. Moving forward to the next 
fifteen years we see another one year increase in life expectancy by Gompertz-
Makeham and about one and a half year increase in life expectancy for Perks. By 
2050, the expected life for East Germany male will increase to 78.2 using Gompertz-
Makeham, and 81.3 using Perks. The difference between the estimates for these two 
models is increasing the more we forecast in the future. Though both are increasing at 
a constant rate, it seems that either Perks is estimating very high or Gompertz-
Makeham is estimating very low. In the coming forty-five years, Gompertz-Makeham 
has estimated an increase in life expectancy of 2.5 years while Perks estimates an 
increase of 5.6 years. This is an enormous difference between the two estimates and 
can lead to many economic problems if we do not choose the right model.  
Let us see if female estimation gives any better results. Female life expectancy at birth 
in East Germany in 2005 was 81.8 years. By 2020, this will increase to 84.4 as 
estimated by Gompertz-Makeham, compared to 84.6 of Perks. 2035 shows an 
increase to 86.7 and 86.4 years respectively. Finally, for 2050 we get 88.9 and 88.1. 
Overall, we have got much closer estimates this time. In forty-five years, female life 
expectancy is forecasted to increase by 7.1 years by Gompertz-Makeham and an 
increase of 6.3 years is forecasted by Perks. This time Gompertz-Makeham estimated 
a higher life expectancy than Perks, but the overall difference for the female estimates 
is minimal.  
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A visualization of this result can be seen in figure 6.3.1. The figure is divided into two 
parts. The left part shows a historic development in the life expectancy from 1956 to 
2004 while the right side shows the forecasted estimates of Gompertz-Makeham 
(gray) and Perks (white). The top plot represents female of East Germany, where as 
the bottom one is for male. Looking at female plot first we observe that both the 
models have close estimates with Perks estimating slightly lower than Gompertz-
Makeham. The future life expectancy is constantly increasing in both cases. In case of 
male, we observe Perks model estimating a constant increase whereas Gompertz-
Makeham start to flat out and the difference between the two estimates is increasing 
for every forecasted year.   
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Fig 6.3.1: G-M and Perks historic & forecasted life expectancy at birth for East Germany 
 
From 1956 to 2005 East Germany has experienced an increase in life expectancy at 
birth of about 10-11 years for both sexes. By the coming 45 years Gompertz-
Makeham forecasts an increase of 2.5 years for male and 7.1 years for female, where 
as Perks forecasts an increase of 5.6 for male and 6.3 years for female. We will be 
looking at the other countries in order to come to a conclusion as it is hard to see any 
pattern for now. 
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Though one country, Germany is divided into East and West. For us it would be 
interesting to see how much the results differ for the two sides. Male life expectancy 
at birth in West Germany in 2020 is forecasted to be 79 years by Gompertz-Makeham 
model and 79.1 using Perks. In 2005, life expectancy at birth for male in West 
Germany was 76.8. This means that according to both Gompertz-Makeham and Perks, 
life expectancy will increase by two years in the first fifteen years. Moving forward to 
the next fifteen years we see another two year increase in life expectancy by 
Gompertz-Makeham and about two and a half year increase in life expectancy for 
Perks. By 2050, the expected life for East Germany male will increase to 83 according 
to Gompertz-Makeham, and 84.3 using Perks. For East Germany, the models had very 
different forecasted life expectancies for male, but in case of West Germany we have 
very close results.   
Moving on to the female estimates, life expectancy of a new born female in West 
Germany in 2005 was 82 years. By 2020, this will increase to 84.7 as estimated by 
Gompertz-Makeham, compared to 83.1 of Perks. 2035 shows an increase to 87.1 and 
85.7 years respectively. Finally, for 2050 we get 89.3 and 88.3. Over the course of 
next 45 years, female life expectancy will increase by 7.3 years according to 
Gompertz-Makeham and by 6.3 years according to Perks. Again, we see close 
estimates for female.   
6.3.2 A quick look at the other countries 
In order to see the kind of pattern these two models follow, it does not hold with one 
example only. We need to look at the other countries as well in order to generalize the 
pattern for the two models. Though the table above contains all the data we need, it is 
often easier to visualize the results to get a better picture. There is no need to go in 
detail for every country to get to a conclusion. Here, we will briefly look at each 
country‟s estimates using the forecasted life expectancy plots available in the 
Appendix A. 
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Starting with England & Wales first, we see a smooth estimation for both the models. 
The estimates seem to be very close, especially in case of male. There is almost no 
difference between the two model‟s forecasted life expectancies at birth for male. 
Both Gompertz-Makeham and Perks show a constant improvement in the life 
expectancies over the coming years for each gender. There is no sign of life 
expectancy at birth flatting out or improvement slowing down in the near future for 
England & Wales.  
Moving on to France, one can yet again see close and smooth estimates for each 
model with constant improvements in life expectancies. The only striking thing here 
is the female curve for Perks. There is an initial decrease in life expectancy the first 
year from 84 years to 83 years, followed by constant improvement. Italy also follows 
the same pattern which we have seen till now, where both the models have close 
estimates and there is a general improvement in life expectancy at birth over the 
coming years for each gender. Though for female we see a slightly different result 
from each model. Where Gompertz-Makeham is improving at the same rate as in the 
past, Perks improvement rate slows down after 2015 and continues to be slow.  
Finally we are looking at Spain. While Gompertz-Makeham is following the same 
trend as seen in all the other countries we have studied, Perks like seen before has the 
tendency to jump up or down the first year of future forecasting, and that is what we 
see here again. This time both the gender estimates decline in the first year, then 
continue to improve at a constant rate in the future.   
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6.3.3 Generalizing the results 
We will not look at each country one by one; instead try to generalize the results. This 
is done with a help of the table below: 
   2020  2035  2050 
Country M F M F M F 
East Germany -1.1 -0.2 -2 0.3 -3.1 0.8 
West Germany -0.1 1.6 -0.5 1.4 -1.1 1 
England&Wales -0.1 0.5 0 0.7 -0.2 0.6 
France -0.2 1.1 -0.7 1.5 -1.1 2 
Spain 1 1.3 1.3 1.1 1.8 0.7 
Italy 0.2 0.3 0.3 1 0.5 1.9 
       
Average -0.1 0.8 -0.3 1.0 -0.5 1.1 
Table 6.3.2: Difference in the forecasted life expectancies of new born male and female for the two models 
 
Table 6.3.2 contains the differences in the forecasted life expectancies estimated by 
the two models for both male and female for the six countries in year 2020, 2035 and 
2050. Note that Russia is not included in the table. This is because as we mentioned 
earlier, Russia‟s data contains bad data which gave strange results. We will discuss 
Russia separately as it is interesting to see how each model react to Russia‟s data. For 
now we concentrate on these six countries. Negative sign shows that Perks has a 
higher estimate and positive shows that Gompertz-Makeham is estimating higher. 
Overall, we see that the differences are very little. The row Average contains the 
average of the differences and that is what we will be looking at.  
Starting with the first average value of male 2020 we see the value -0.1, meaning that 
overall there is 0.1 year difference in the forecasted life expectancy at birth of a male. 
Here, negative sign indicates that Perks‟s estimates higher than Gompertz-Makeham. 
Female for the same year shows 0.8. As the value is positive, it means that in general 
Gompertz-Makeham is estimating life expectancy at birth of a female 0.8 years more 
than what Perks has estimated. Moving to 2035 we see -0.3, indicating that Perks is 
estimating 0.3 years more than Gompertz-Makeham and so on. One thing that strikes 
is that for every female estimation Gompertz-makeham in general is estimating higher 
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life expectancies at birth than Perks, and for the male it is the opposite. The reason for 
that is not clear, but is something that strikes at a first glance of the table.     
The results of table 6.3.2 gives us the idea that although there are differences in the 
estimates of each model for each country, in general both the models give very close 
forecasted life expectancies at birth. Next we want to see how much life expectancy at 
birth is forecasted to increase over the next 45 years. Remember that we start at 2005 
and not 2008; therefore we have 45 years between 2005 and 2050.  
Table 6.3.3 shows the forecasted increase in life expectancies at birth from 2005 to 
2050 for both genders and for both the models. The table contains the values for each 
country separately. We can easily compare the countries, genders or models together 
by looking at the table. East Germany male gives the most unbalanced result. We see 
a difference of 3.1 years between the estimates of the two models. Here, negative sign 
suggests that Perks is estimating higher than Gompertz-Makeham. Otherwise, the 
values are close. To generalize the result in order to come to a conclusion, we are 
going to look at the average values. Starting with Gompertz-Makeham male, we see 
that on average an increase in life expectancy at birth of about 5.3 years is forecasted 
over the 45 years. Perks forecast an increase of 5.8 years. So the difference between 
these two models on average is of 0.5 years. For female, Gompertz-Makeham 
forecasts an increase of 6.7 years compared to 5.5 of Perks, thus making the 
difference to be 1.2 years. Like we saw earlier, Perks seems to estimate a bit higher 
for male while Gompertz-Makeham estimates higher for female in general.   
 
Country GMmale Pmale Diffmale GMfem Pfem DiffFem 
East Germany 2.5 5.6 -3.1 7.1 6.3 0.8 
West Germany 6.2 7.3 -1.1 7.3 6.3 1 
England&Wales 5.8 6 -0.2 5.5 4.9 0.6 
France 6.2 7.3 -1.1 7.3 5.3 2 
Spain 5.7 3.9 1.8 4.9 4.2 0.7 
Italy 5.4 4.9 0.5 7.8 5.9 1.9 
       
Average 5.3 5.8 -0.5 6.7 5.5 1.2 
Table 6.3.3: Forecasted increase in life expectancies of new born male and female 
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The results so far have been convincing. We have seen a further improvement in 
future life expectancy. Looking at Europe in general, over the course of the last 45-50 
years, life expectancy at birth has increased at a constant rate in the past and is 
forecasted to continue to rise in the future. 
6.3.4 Russia 
As seen earlier, Russia has a very unique mortality trend. It is very different from the 
other countries we have studied. This led us to look at Russia separately. Russia is a 
very important part of Europe, and therefore it had to be included in the thesis. At that 
point we had no idea how the data looks and how the results going to look like.  
The aim here is to see how each model reacts to the difficult data. Till now we have 
seen a very fluctuating mortality trend for Russia. Strangely, mortality seems to 
increase over the years. This can not be true for the future as things are way different 
now. We expect life expectancy at birth to improve over the coming years. Let us see 
how the models react to Russia‟s data.  Figure 6.3.2 shows the forecasted life 
expectancy at birth for Russia for both male and female. The lighter shade shows the 
development in life expectancy at birth from 1959 to 2006, while the darker portion is 
the forecasted life expectancy till 2050. Top curve is for female while the bottom 
curve shows male data and estimation. Perks forecasted life expectancy is the white 
line while gray line signifies Gompertz-Makeham.  
Starting with the female plot first, we see an improvement in life expectancy in the 
early 1960s, fluctuation till the 80s, a sudden decline in the early 90s followed up by 
another snake like trend. Male plot shows a similar pattern. With this kind of 
unbalanced trend as a base for our future forecasting, it is hard to get realistic life 
expectancies for the future. The key to forecasting in the future is the value of drift 
factor μ. But with so much uncertainty in the past, it is hard to get a good solid drift 
value. So the results we see in the figure are not very surprising. This uncertainty has 
given us the chance to look at each model in an extreme case.  
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It is not hard to see which model handled the extreme data best. While for female, 
both models forecast very close life expectancies, male plot gives a very different 
picture. Perks (white) shows a decline in the future life expectancies at birth, but the 
rate of decline is low. On the other hand we have Gompertz-Makeham which shows a 
very high rate of decline in life expectancies in the future. While Perks almost flats 
out, Gompertz-Makeham is not able to forecast the future life expectancies correctly, 
especially for male.  
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Fig 6.3.2: G-M and Perks historic & forecasted life expectancy for Russia 
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7. Economic Consequences 
This chapter focuses on the economic consequences faced by pension funds and insurance 
companies due to mortality decline. We will look at how much of an effect it makes 
economically and compare the effects of the two models.  
7.1 Longevity: A concern 
Longevity is a huge concern for insurance companies and pension planners. When 
people tend to live longer, a lot more is paid to them after their retirement. If we look 
at the life expectancy of female in East Germany, we estimated earlier an increase of 
six to seven years in life expectancy over the next forty-five years. This means that for 
every single female, the pension fund or the insurance company has to pay an extra 
payment for six-seven years more than what we are paying now. By now we mean 
2005 as this was the latest data year we had for East Germany. Let us look at a 
scenario. Assume that females in general get a pension of $1000 per year in East 
Germany. Life expectancy of a female in East Germany is 81.8 years at the moment. 
By 2050 it is estimated to be around 88.5, meaning that pension planers needs to pay 
an extra $6700 per female than what they are paying now. Assuming further that the 
portfolio contains 100 female, the net extra amount that will be paid by 2050 equals 
$670000, which is an enormous amount.  
This is a very serious matter and the insurance companies and pension planers need to 
work on how to handle these growing mortality concerns. For many years, the 
governments and insurance companies have had problem like these with female. They 
tend to live longer than men which results in a lot of extra costs. But now we are 
having similar problems with men. Though it might sound good that people tend to 
live longer now than ever before and will continue to improve their survival 
probability over the years, it is a concern for those in the retirement business. Pension 
rules are changed every now and then in order to adjust to the growing survival rate.    
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Actuaries from years have been trying to find new survival models in order to 
estimate the closest and realistic mortality rate. Here, we have estimated future 
mortality using the mostly used survival models. And the results have been 
convincing so far. In the coming section we will look at how much the single 
premium will increase over the years in order to manage longevity.  
7.2 Single Premium 
The net single premium is the amount of money that would have to be collected at the 
time a policy is issued to assure that there will be enough money to pay the 
death/pension benefit of the policy, assuming that interest is earned at the expected 
rate and that claims occur at the expected rate. It has the form 
                                                 0
111
max( ,0)
,
r
t
k l l
v tPx
 

                                          (7.2.1) 
where l0 is the starting age, lr is the retirement age, v
t
 is the discount factor 1 (1 )tr . 
We have assumed that there is a constant interest rate of 4% for all the countries with 
retirement age 67. 
Figure 7.2.1 shows the estimated single premium for East Germany female for year 
2005, 2025 and 2050. The premiums are estimated using the equation 7.2.1. One can 
see a clear constant increase in premium over the years for all ages. With a mortality 
decline, an increase in premium is needed to cover up for the extra costs of living 
longer. Black, green and cyan colored lines show net single premium estimated using 
Perks model, while the red, blue and violet plots represent the estimates of Gompertz-
Makeham. Both models show an increase in premium over the years. Gompertz-
Makeham shows a slightly higher premium than Perks. But the difference between the 
two estimates is minimal.  
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Fig 7.2.1: Forecasted single premiums for East Germany female 
7.3 How the single premium works 
Premium that we get is not an amount, rather a scaling factor. We can show use of it 
using an example. We are interested in the total reserve we need to have in order to 
fulfill person x‟s pension obligations. Assuming x is 40 years old and has a benefit of 
$1000, and assuming an administrative cost of 3%, we can find her total reserve: 
Total reserve = Single premium * benefit * 1.03 (administrative cost)                (7.3.1) 
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A forty year old female has a premium of about 4 in 2005, which gives us a total 
reserve of $4120. This means that pension fund need to set aside $4120 for person x 
in order to fulfill her pension obligations after her retirement. By 2050, premium 
increases to 5 which then increases total reserve to $5150. This means that over the 
course of 45 years, the reserve has to be increased by $1030 which gives increase of 
25%. Note that we have not taken inflation and other factors into consideration.  
7.4 Comparing premiums of the two models 
Tables 7.1 and 7.2 show the estimated single premium values for each country for 
year 2010, 2030 and 2050, and for age 30, 60 and 90. Table 7.1 contains the estimates 
of Gompertz-Makeham and 7.2 have Perks single premiums. The models have pretty 
close estimates and both follow a general pattern. Premiums have increased over the 
years for every age, for every country. The only exception is of Russia like we have 
seen earlier. In case of Russia, the premiums are decreasing every year. This is 
because survival probabilities for Russia are decreasing every year. It is very strange, 
but that is what both the models reveal. So actuaries in Russia must be very careful 
when forecasting the future mortality and premiums because the estimates we get 
does not seem to be realistic. It is very tough to forecast future mortality for Russia 
and other methods need to be considered.   
Having seen the tables and plot 7.2.1, one can see that the premiums increase 
smoothly till a certain age and then follow a downward trend. The top point is met at 
the age of 67. This is when a person retires. Though retirement age is different from 
country to country, we have made it a constant for every country we tested in other to 
compare the results. The top point is at age 67 because after this the member of a 
pension policy changes state from active to retired. After age 67 the premium value 
starts to decrease because survival probabilities at old age are lower than at early age, 
thus automatically reducing the premiums.   
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Gompertz-Makeham 
    2010       2030       2050   
Country \ Age 30 60 90   30 60 90   30 60 90 
East Germany 
    
3.0  
   
10.1  
   
4.3   
     
3.3  
    
10.9  
    
5.1   
    
3.5  
   
11.7  
    
6.0  
West Germany 
    
3.2  
   
10.9  
   
5.2   
     
3.6  
    
11.8  
    
6.0   
    
3.8  
   
12.6  
    
6.9  
Russia 
    
2.3  
    
8.4  
   
4.4   
     
2.2  
      
8.1  
    
4.3   
    
2.1  
     
7.8  
    
4.3  
England&Wales 
    
3.1  
   
10.5  
   
5.2   
     
3.4  
    
11.2  
    
5.8   
    
3.6  
   
11.9  
    
6.5  
France 
    
3.4  
   
11.5  
   
5.9   
     
3.7  
    
12.4  
    
6.7   
    
4.0  
   
13.1  
    
7.6  
Spain 
    
3.3  
   
11.3  
   
5.3   
     
3.5  
    
11.9  
    
5.7   
    
3.6  
   
12.4  
    
5.9  
Italy 
    
3.4  
   
11.5  
   
5.8    
     
3.7  
    
12.3  
    
6.7    
    
4.0  
   
13.2  
    
7.8  
Table 7.1: Gompertz-Makeham single premiums for each country 
 
 
Perks 
    2010       2030       2050   
Country \ Age 30 60 90   30 60 90   30 60 90 
East Germany 
    
3.0  
    
9.9  
   
4.5   
     
3.2  
    
10.7  
    
5.0   
    
3.5  
   
11.5  
    
5.5  
West Germany 
    
2.8  
    
9.7  
   
5.5   
     
3.1  
    
10.7  
    
6.7   
    
3.4  
   
11.6  
    
7.9  
Russia 
    
2.0  
    
7.5  
   
4.0   
     
2.0  
      
7.2  
    
3.3   
    
2.0  
     
7.0  
    
2.8  
England&Wales 
    
2.8  
    
9.5  
   
4.7   
     
3.0  
    
10.2  
    
5.2   
    
3.3  
   
10.9  
    
5.9  
France 
    
3.0  
   
10.3  
   
6.9   
     
3.3  
    
11.1  
    
6.2   
    
3.5  
   
11.7  
    
6.5  
Spain 
    
2.9  
   
10.0  
   
5.6   
     
3.2  
    
10.7  
    
5.6   
    
3.4  
   
11.3  
    
5.8  
Italy 
    
3.2  
   
10.5  
   
5.0    
     
3.4  
    
11.3  
    
5.2    
    
3.6  
   
11.9  
    
5.4  
Table 7.2: Perks single premiums for each country 
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In order to generalize the behavior of the two models, we will consider the results of 
all the countries together.  By thorough investigation we found out that on average 
Gompertz-Makeham estimates 0.3 premium points higher than Perks for age 30, 1.0 
premium point higher for age 60 and 0.4 premium point higher for age 90. This means 
that overall Gompertz-Makeham estimates higher premiums than Perks for every age 
and for every year. And the difference in premiums increases more with age moving 
towards 67 and then starts to decrease again. This can also be seen from figure 7.2.1.  
The question is which model should we go for? We can look at an example. Consider 
a female aged 30, 60 and 90. Using 7.3.1 we will calculate the reserves for both the 
models and compare the difference. Let benefit = $1000, administrative cost = 3%, 
single premium for Perks = 1 for each age, single premium for Gompertz-Makeham = 
1.3, 2 and 1.4. Total reserve for Perks equals $1030 and $1339 for Gompertz-
Makeham for age 30. For age 60 we get $1030 and $2060, and for age 90 we get 
$1030 and $1442. It was a very simple example with very small values, but there is a 
striking difference in total reserve for the two models. In real world example, a slight 
difference in the premium can have such a huge impact when we consider big 
companies and big portfolios. We believe that it is good to have more in the reserve 
than to have too little. Therefore Gompertz-Makeham seems to be a better alternative.  
7.5 Management of mortaltiy risk 
This section gives a brief insight on how to manage and cop with mortality risk. What 
measures pension funds and other insurance institutes can take to reduce or eliminate 
the economic affect of mortality risk in the future. One of the key problems facing 
annuity providers is mortality risk, the risk of underestimating mortality 
improvements. We have seen two models which give different single premiums and 
different future mortality trends. Thus the question of choosing the right survival 
model to explain current mortality trends and forecast future life expectancy is of 
utmost importance for risk management and valuation of insurance portfolios.  
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Mortality risk can be significant for financial institutions such as life assurers and 
pension plans. It might not be the largest risk they face, but it is often significant and 
one that cannot be ignored. We have assembled a few points under which we feel can 
be used for managing mortality risk: 
 They can enter into a variety of forms of full or partial reinsurance, in order to 
hedge downside mortality risk.  
 Assurers can diversify their mortality risk across product ranges, regions and 
socioeconomic groups.  
 Pension plans can arrange a full or partial buyout of their liabilities by a 
specialist insurer. Small pension plans in the UK are exposed to considerable 
non-systematic mortality risk and often, therefore, purchase annuities from a 
life office for employees at the time of their retirement, thereby removing the 
tail mortality risk.  
 Survivor bonds can be used in helping to hedge mortality risk 
 Increase the premium on the products in order to cop with future mortality risk. 
The more reserve, the better. 
Unfortunately, due to lack of time, not much emphasis was put into this section. There 
are many ways to tackle and manage the mortality risk. The one mentioned above was 
just a brief idea which we felt need to be introduced as we are forecasting future 
mortality trend.  
 62 
 
 63 
8. Conclusion 
In this chapter we conclude our work with a summary of the thesis. Known weaknesses of 
our work are presented. Future work ideas are also discussed in the end. 
8.1 Summary and conclusion 
In this thesis two dynamic and stochastic survival models are discussed. The objective 
of this thesis was to test the two models and decide which one is most suitable for 
Europe. Each model is first run independently on past data for all the countries 
considered. The mortality trends from the past are simulated and compared to the 
historic data in order to test the goodness of fit. The tested models are then used to 
forecast mortality trends in the future. This involves the forecasting of future survival 
rates and life expectancies at birth. Finally, single premiums are estimated for each 
model. The results of the two models have been compared along the way to see which 
model suits best for Europe.     
At the minimum, a good model should be consistent with historical patterns of 
mortality. If that is not the case, much greater doubt must be placed on the validity of 
any forecasts produced by the model. Our testing of the models on past data revealed 
that apart from the early age, Gompertz-Makeham fits well and is consistent with the 
historical patterns of mortality. Perks on the other hand is not able to capture the 
historical mortality trend that well. It is clear that Perks model under estimates for the 
young and old age group and over estimates for the middle age. The most important 
age group in actuarial context is the middle age group, one that needs to be most 
accurately calculated, but that is exactly where Perks fails.  By over estimating the 
death rate, Perks automatically under estimates the survival rate for the middle age 
group. Results indicate that Perks mortality model may not be effective in capturing 
the patterns of decline in mortality in European countries accurately. Therefore, the 
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use of Perks models for predicting future mortality trends is likely to be unwarranted, 
potentially leading to serious financial, economic and demographic miscalculations. 
Having also looked at the future mortality trends forecasted by the two models, we 
can say that Perks model seem to be unpredictable. It has the tendency to act strangely 
in certain occasions. This is best observed in the life expectancy plots. While 
Gompertz-Makeham follows a general pattern for each country, Perks estimates may 
vary from country to country.  
Gompertz-Makeham in general gives higher premiums, thereby calculating better 
reserves, and thus reducing the future morality risk. Perks on the other hand gives 
lower premiums and show less improvements in mortality in the future. And knowing 
its behavior from the past mortality trends, it can not be fully trusted. Having said 
that, some points are worth mentioning. Both models do have close estimates and 
both reveal the same picture of the future mortality trends. In case of Russia, Perks 
seemed to handle the data way better than Gompertz-Makeham.  
Our analysis might suggest that Gompertz-Makeham model is satisfactory, but further 
forensic investigation might reveal some pitfalls that need corrective work. We have a 
case of over estimation for the early age group which needs to be considered. There 
are still considerable challenges ahead. The existing model needs further refinement 
in order to manage mortality risk in the most effective way.   
In conclusion, the results from this thesis suggest that Gompertz-Makeham is a more 
reliable survival model. The extra parameter in Gompertz-Makeham model makes it a 
more flexible and reliable than Perks. Having survived for 150 years, one can only say 
that the model is good.  
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8.2 Known weaknesses 
One thing that might have helped in claiming better results is the use of drift μ 
effectively. In our analysis, we have used a constant drift for every year to calculate 
the future morality trends. Had we changed the drift for every year, we might have got 
better estimates. This is thought to be one of the weaknesses in our estimation.   
8.3 Future work 
Here we outline the ideas and plans for the future work. We look at the things that 
were planned but could not be completed due to limited time, therefore can be 
considered as future work.  
Firslty, we wanted to check if mortality trend in one country or in one gender had any 
effect on the trend of another country or gender. Future work should analyze 
correlation as it would be interesting to see the linear relationships between European 
countries and genders which can be a useful study for insurance companies which 
operate throughout Europe.   
Secondly, we touched slightly on the topic: management of mortality risk. It is a broad 
field and one which is very important for both the insurance companies and pension 
planners. Therefore as a future work one can look at swaps, survivor bonds etc by 
using our work.  
Finally, future work should consist of solidification of the work presented in this 
thesis. One element to look at is the effect of changing the drift for every year.  
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Appendix A 
Tables showing drifts for all the countries considered. 
Gompertz-Makeham 
    Female       Male   
Country 1   2   3     1   1   3   
East Germany  -3.45E-05 -4.54E-08 -4.88E-05  -5.12E-05 3.67E-07 -3.26E-04 
West Germany  -2.69E-05 -9.04E-08 7.71E-05  -4.32E-05 -1.19E-07 -9.23E-05 
Russia  -3.02E-05 3.42E-07 -1.99E-04  -7.11E-05 1.58E-05 -6.44E-04 
England&Wales -2.38E-05 -1.37E-07 5.13E-05  -2.82E-05 -2.99E-07 1.26E-05 
France  -4.36E-05 -1.20E-07 1.12E-04  -6.10E-05 4.09E-08 -1.87E-04 
Italy  -5.40E-05 -5.89E-08 1.18E-06  -6.67E-05 1.59E-08 -1.57E-04 
Spain  -7.17E-05 -1.46E-07 3.11E-04   -9.03E-05 -2.05E-08 -1.30E-04 
Table1:
i , the mean of the difference between Gompertz-makeham parameters, for male and female mortality 
for ages 0-111 in 7 countries. 
 
Perks 
  Female     Male   
Country 1   2             1   2   
East Germany  -4.02E-02 3.26E-04 -1.73E-02 9.66E-05 
West Germany  -2.24E-03 -1.76E-04 -4.14E-03 -1.49E-04 
Russia  -3.60E-02 5.71E-04 -1.45E-02 3.70E-04 
England&Wales -1.80E-02 7.46E-05  -1.45E-02 1.59E-05 
France  -4.78E-02 4.54E-04 -1.80E-02 5.86E-05 
Italy  -7.26E-02 7.37E-04  -4.48E-02 4.84E-04 
Spain  -5.72E-02 5.99E-04 -5.72E-02 5.99E-04 
Table1: i , the mean of the difference between Perks parameters, for male and female mortality for ages  0-111 
in 7 countries. 
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Life Expectancy plots: 
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Italy: 
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Appendix B 
CODE: 
This is the code for East Germany female. Mainly the code is for 
Gomepertz-Makeham, but Perks modifications are added. As both the models 
follow similar routines, the whole of Perks code is not shown. Just the 
model description and a few other details included. For male and for all 
the other countries we have similar code with just a few modifications and 
therefore not included in the Appendix. 
 
##FEMALE## 
#historic plot 
q=read.table("EG1956f.txt") 
w=read.table("EG1976f.txt") 
e=read.table("EG1996f.txt") 
r=read.table("EG2004f.txt") 
 
 
bind=cbind(q$V1,w$V1,e$V1,r$V1) 
par(mfrow=c(2,1)) 
matplot(bind[,1:4],type="l",ylab="Death 
probability",xlab="Age",main="Female historic data",lty=1) 
cols = c("black","red","green","blue") 
legend("topleft",c("1956","1976","1996","2004"),fill=cols) 
 
#Getting the estimates 
fem=read.table("gompEGfemale.txt") 
 
 
#Finding death probability 
Nq.fem=matrix(NA,49,111) 
k=1 
for(t in 1:49) 
{ 
 for(x in 0:110) 
 { 
  Nq.fem[t,x+1]=1-exp((-fem[t,2]*k)-
((fem[t,3]/fem[t,4])*(exp(fem[t,4]*(k+x))-exp(fem[t,4]*x)))) 
  
 } 
} 
 
#Plotting the mortality curve 
R=cbind(Nq.fem[1,],Nq.fem[21,],Nq.fem[41,],Nq.fem[49,]) 
matplot(R[,1:4],type ="l",ylab="Death probability",xlab="Age",main="Female 
estimated data",lty=1) 
cols = c("black","red","green","blue") 
legend("topleft",c("1956","1976","1996","2004"),fill=cols) 
 
#Dividing into four age groups 
R=cbind(Nq.fem[1,],Nq.fem[21,],Nq.fem[41,],Nq.fem[49,],q,w,e,r) 
par(mfrow=c(2,2)) 
age1=seq(5,25,by=1) 
age2=seq(26,50,by=1) 
age3=seq(51,75,by=1) 
age4=seq(76,111,by=1) 
matplot(age1,R[5:25,],type ="l", xlab="Age", ylab="Death 
probability",lty=1) 
matplot(age2,R[26:50,],type ="l", xlab="Age", ylab="Death 
probability",lty=1) 
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matplot(age3,R[51:75,],type ="l", xlab="Age", ylab="Death 
probability",lty=1) 
matplot(age4,R[76:111,],type ="l", xlab="Age", ylab="Death 
probability",lty=1) 
cols = c("black","red","green","blue") 
legend("topleft",c("1956","1976","1996","2004"),fill=cols) 
 
 
#MALE + FEMALE# 
T=cbind(Nq.fem[1,],Nq.male[1,]) 
par(mfrow=c(2,2)) 
matplot(T[,1:2],type ="l",ylab="Death probability",xlab="Age",main="Male 
vs Female",lty=1) 
cols = c("black","red") 
legend("topleft",c("female 1956","male 1956"),fill=cols) 
 
T=cbind(Nq.fem[21,],Nq.male[21,]) 
matplot(T[,1:2],type ="l",ylab="Death probability",xlab="Age",main="Male 
vs Female",lty=1) 
cols = c("black","red") 
legend("topleft",c("female 1976","male 1976"),fill=cols) 
 
T=cbind(Nq.fem[41,],Nq.male[41,]) 
matplot(T[,1:2],type ="l",ylab="Death probability",xlab="Age",main="Male 
vs Female",lty=1) 
cols = c("black","red") 
legend("topleft",c("female 1996","male 1996"),fill=cols) 
 
T=cbind(Nq.fem[49,],Nq.male[49,]) 
matplot(T[,1:2],type ="l",ylab="Death probability",xlab="Age",main="Male 
vs Female",lty=1) 
cols = c("black","red") 
legend("topleft",c("female 2004","male 2004"),fill=cols) 
 
 
#Observed vs Estimated plots 
#Female 
par(mfrow=c(2,2)) 
plot(log(q$V1),xlab="age",ylab="log(qtx)",main="1956") 
points(log(Nq.fem[1,]),type="l",col="red") 
plot(log(w$V1),xlab="age",ylab="log(qtx)",main="1976") 
points(log(Nq.fem[21,]),type="l",col="red") 
plot(log(e$V1),xlab="age",ylab="log(qtx)",main="1996") 
points(log(Nq.fem[41,]),type="l",col="red") 
plot(log(r$V1),xlab="age",ylab="log(qtx)",main="2004") 
points(log(Nq.fem[49,]),type="l",col="red") 
 
#Male + Perks estimates combined 
par(mfrow=c(2,2)) 
plot(log(a$V1),xlab="age",ylab="log(qtx)",main="1956") 
points(log(Nq.male[1,]),type="l",col="red") 
#points(log(Pq.male[1,]),type="l",col="blue") 
plot(log(s$V1),xlab="age",ylab="log(qtx)",main="1976") 
points(log(Nq.male[21,]),type="l",col="red") 
#points(log(Pq.male[21,]),type="l",col="blue") 
plot(log(d$V1),xlab="age",ylab="log(qtx)",main="1996") 
points(log(Nq.male[41,]),type="l",col="red") 
#points(log(Pq.male[41,]),type="l",col="blue") 
plot(log(f$V1),xlab="age",ylab="log(qtx)",main="2004") 
points(log(Nq.male[49,]),type="l",col="red") 
#points(log(Pq.male[49,]),type="l",col="blue") 
 
 
#Correlation 
malepar=male$V2,male$V3,male$V4 
fempar=fem$V2,fem$V3,fem$V4 
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correlationEG=cor(malepar,fempar) 
 
 
#Percentiles 
#Female 
y=49 
p.fem1=array(0,y) 
p.fem2=array(0,y) 
p.fem3=array(0,y) 
 
a=111 
pkx=function(x) 
{ 
 P=1-q.fem[x,1] 
 for(i in 1:a) 
 {  
  if(P>0.5){ 
   P=P*(1-q.fem[x,1+i]) 
  } 
  else{ 
   break 
  } 
 } 
 return(i)  
} 
 
for(year in 1:y) 
{ 
 p.fem1[year]= pkx(year) 
 
} 
 
#Plot 
year=seq(1956,2005,by=1) 
d=p.fem1 
e=p.fem2 
f=p.fem3 
 
fbind=cbind(d,e,f) 
par(mfrow=c(1,2)) 
matplot(year,fbind[,1:3],ylim=c(20,100),ylab="age",type 
="l",lty=1,main="Female death pop. %tile") 
cols = c("black","red","green") 
legend("bottomright",c("20%","50%","80%"),fill=cols) 
 
 
#percentage decrease in death probability 
a=q.fem[,21] 
b=q.fem[,41] 
c=q.fem[,61] 
d=q.fem[,81] 
pa=array(NA,49) 
pb=array(NA,49) 
pc=array(NA,49) 
pd=array(NA,49) 
 
pa[1]=0 
for(i in 1:48) 
{ 
 pa[i+1]=((a[i+1]-a[1])/a[1])*100 
} 
pb[1]=0 
for(i in 1:48) 
{ 
 pb[i+1]=((b[i+1]-b[1])/b[1])*100 
} 
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pc[1]=0 
for(i in 1:48) 
{ 
 pc[i+1]=((c[i+1]-c[1])/c[1])*100 
} 
pd[1]=0 
for(i in 1:48) 
{ 
 pd[i+1]=((d[i+1]-d[1])/d[1])*100 
} 
 
year=array(seq(1956,2004,by=1),c(49,1)) 
percentage=cbind(pa,pb,pc,pd) 
matplot(year,percentage[,1:4],ylim=c(-1,1),ylab="% of mu1956",type 
="l",lty=1) 
cols = c("black","red","green","blue") 
legend("topright",c("20","40","60","80"),fill=cols) 
 
 
#Forecasting future mortality trends 
#Female 
#Estimation 
fem=read.table("gompEGfemale.txt") 
 
#Finding mu 
Fmu1=mean(diff(log(fem[,2]))) 
Fmu2=mean(diff(log(fem[,3]))) 
Fmu3=mean(diff(log(fem[,4]))) 
 
#Finding A1, A2 and A3 
y=46 
Fa1=array(NA,y+1) 
Fa1[1]=log(fem[49,2]) 
Fa2=array(NA,y+1) 
Fa2[1]=log(fem[49,3]) 
Fa3=array(NA,y+1) 
Fa3[1]=log(fem[49,4]) 
 
a1=diff(log(fem$V2)) 
b1=diff(log(fem$V3)) 
c1=diff(log(fem$V4)) 
d1=cbind(a1,b1,c1) 
covF=cov(d1) 
mean=c(0,0,0) 
 
Ef=array(NA,c(1000,3)) 
 
for(i in 1:y) 
{ 
 for(a in 1:1000) 
 { 
  Ef[a,]=rmvnorm(1,mean,covF) 
 } 
 Ef1=mean(Ef[,1]) 
 Ef2=mean(Ef[,2]) 
 Ef3=mean(Ef[,3]) 
 Fa1[i+1]=Fmu1+Fa1[i]+Ef1 
 Fa2[i+1]=Fmu2+Fa2[i]+Ef2 
 Fa3[i+1]=Fmu3+Fa3[i]+Ef3 
} 
 
Fa=cbind(Fa1,Fa2,Fa3) 
expFa=exp(Fa) 
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#For Perks 
mPFa1=array(NA,c(y+1,1000)) 
mPFa1[1,]=-Pfem[54,2] 
mPFa2=array(NA,c(y+1,1000)) 
mPFa2[1,]=Pfem[54,3] 
 
Pa1=diff(-Pfem$V2) 
Pb1=diff(Pfem$V3) 
Pc1=cbind(Pa1,Pb1) 
PcovF=cov(Pc1) 
Pmean=c(0,0) 
for(s in 1:1000) 
{ 
 for(i in 1:y) 
 { 
  Ef=rmvnorm(1,Pmean,PcovF)  
  mPFa1[i+1,s]=PFmu1+mPFa1[i,s]+Ef[1] 
  mPFa2[i+1,s]=PFmu2+mPFa2[i,s]+Ef[2] 
 } 
} 
 
meanPFa1=array(NA,48) 
meanPFa2=array(NA,48) 
 
#Ploting the parameter distribution 
par(mfrow=c(2,2)) 
hist(mPFa1[2,],main="Perks first parameter",xlab="Theta1") 
hist(mPFa2[2,],main="Perks second parameter",xlab="Theta2") 
 
 
for(m in 1:48) 
{ 
 meanPFa1[m]=mean(mPFa1[m,]) 
 meanPFa2[m]=mean(mPFa2[m,]) 
} 
 
 
#Finding death probability 
q.fem=matrix(NA,y,111) 
k=1 
for(t in 1:y) 
{ 
 for(x in 0:110) 
 { 
  q.fem[t,x+1]=1-exp((-expFa[t,1]*k)-
((expFa[t,2]/expFa[t,3])*(exp(expFa[t,3]*(k+x))-exp(expFa[t,3]*x)))) 
  
 } 
} 
 
test=matrix(NA,t,111) 
t=50 
qkx=function(k,x,sex) 
{ 
  
} 
 
for(age in 0:110) 
{ 
 for(i in 1:t) 
 { 
  test[i,age+1]=1-exp(-(fem[1,2]+fem[1,3]*exp(fem[1,4]*x))) 
  
 } 
}  
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#Transfering qkx to tQx array 
tQx=array(1,c(92,92)) 
 
for(i in 1:92) 
{ 
 k=18+i 
 for(j in 1:92) 
 { 
  if(j+k>111) 
   break 
  else  
   tQx[i,j]=qx[1,j+k]     
 } 
} 
 
#Survival Probability 
tPx=array(0,c(92,92)) 
tPx[,1]=1 
 
for(x in 1:92) 
{ 
 for(t in 2:92) 
 { 
  tPx[x,t]=tPx[x,t-1]*(1-tQx[x,t-1]) 
 } 
} 
 
#Single Premium 
EP2=array(0,92) 
r=0.04 
 
for(x in 1:91) 
{ 
 lo=x+19 
 lr=67 
 t=max(lr-lo,1) 
 l=91 
 P=tPx[x,t] 
 Premie=P/((1+r)^t) 
 for(i in t:l) 
 {   
  Premie=Premie+((tPx[x,i+1])/((1+r)^(i+1))) 
 } 
 EP2[x]=Premie 
} 
 
} 
 
meanEP=array(NA,92) 
for(i in 1:92) 
{ 
 meanEP[i]=mean(EP[,i]) 
} 
 
varEP=array(NA,92) 
for(i in 1:92) 
{ 
 varEP[i]=var(EP[,i]) 
} 
 
#matplot 
age=matrix(seq(20,111,by=1),92,10) 
Tage=t(age) 
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#EPbind=cbind[] 
par(lwd=1) 
matplot(Tage,EP,ylab="Premium",type ="l",lty=1) 
par(lwd=2) 
age2=array(seq(20,111,by=1),c(92,1)) 
lines(age2,meanEP) 
 
#per year 
age=matrix(seq(20,111,by=1),92,1) 
EPpy=cbind(EP1,EP2,EP3,EP4,EP5) 
matplot(age,EPpy,xlab="age",ylab="Premium",type ="l",main="One-time 
premium",lty=1) 
cols = c("black","red","green","blue","cyan") 
legend("topright",c("2005","2015","2025","2035","2050"),fill=cols) 
 
 
#Expected life for 20-111 
ExpLife4=array(0,92) 
for(x in 1:92) 
{ 
 ExpLife4[x]=sum(tPx[x,]) 
} 
 
age=array(seq(20,111,by=1),c(1,92)) 
plot(age,ExpLife3,type="l",ylab="Life Expectancy",col="red") 
 
#Life expectancy at birth 
#female 
tPa=array(0,c(46,111)) 
tPa[,1]=1 
 
for(a in 1:46) 
{ 
 for(t in 2:111) 
 { 
  tPa[a,t]=tPa[a,t-1]*(1-q.fem[a,t-1]) 
 } 
} 
 
ExpLifeGMf=array(0,46) 
for(x in 1:46) 
{ 
 ExpLifeGMf[x]=sum(tPa[x,]) 
} 
 
 
 
#Forecasted life expectancy plots 
require(gplots) 
 
set.seed(120) 
 
# compute the limits of the graph 
ylim <- c(65,90) 
 
# prepare the space where to plot 
opar <- par(mar=c(4,4,2,2),las=1) 
 
year=array(seq(1956,2050,by=1),c(95,1)) 
 
plot(year,EX1,ylim=ylim,type="n",ylab="Age",main="Life Expectancy - 
Historic & Forecasting") 
usr <- par("usr") 
 
# split the figure in two parts 
#   - the part used to fit the model 
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rect(usr[1],usr[3],2004,usr[4],border=NA,col="hotpink3") 
 
#   - the part used to make the forecast 
rect(2004,usr[3],usr[2],usr[4],border=NA,col="hotpink4") 
 
abline(h=(65:90), col ="black" , lty =3) 
 
lines(1956:2004,EX1[1:49],lwd=2 ) 
lines(1956:2004,EX2[1:49],lwd=2) 
lines(2004:2050,EX1[49:95],lwd=2,col ="white") 
lines(2004:2050,EX3[49:95],lwd=2,col ="gray") 
lines(2004:2050,EX2[49:95],lwd=2,col ="white") 
lines(2004:2050,EX4[49:95],lwd=2,col ="gray") 
 
box() 
 
 
ELf=read.table("ELfem.txt") 
ELm=read.table("ELmale.txt") 
 
ELfem=array(0,0,c(49,1)) 
ELmale=array(0,0,c(49,1)) 
for(i in 1:49) 
{ 
 ELfem[i]=ELf[i,] 
 ELmale[i]=ELm[i,] 
} 
 
EX1=array(0,c(95,1)) 
for(i in 1:49) 
{ 
 EX1[i]=ELfem[i] 
} 
for(i in 50:95) 
{ 
 EX1[i]=ExpLifePf[i-49] 
} 
 
EX2=array(0,c(95,1)) 
for(i in 1:49) 
{ 
 EX2[i]=ELmale[i] 
} 
for(i in 50:95) 
{ 
 EX2[i]=ExpLifePm[i-49] 
} 
 
EX3=array(0,c(95,1)) 
for(i in 1:49) 
{ 
 EX3[i]=ELfem[i] 
} 
for(i in 50:95) 
{ 
 EX3[i]=ExpLifeGMf[i-49] 
} 
 
EX4=array(0,c(95,1)) 
for(i in 1:49) 
{ 
 EX4[i]=ELmale[i] 
} 
for(i in 50:95) 
{ 
 EX4[i]=ExpLifeGMm[i-49] 
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} 
 
 
#Goodness of fit for the rest of the countries 
par(mfcol=c(2,3)) 
#FRANCE 
plot(log(Fw$V1),xlab="age",ylab="log(qtx)",main="France-1970") 
points(log(Fq.fem[21,]),type="l",col="red") 
points(log(PFq.fem[21,]),type="l",col="green") 
plot(log(Fr$V1),xlab="age",ylab="log(qtx)",main="France-2005") 
points(log(Fq.fem[56,]),type="l",col="red") 
points(log(PFq.fem[56,]),type="l",col="green") 
 
#SPAIN 
plot(log(Sw$V1),xlab="age",ylab="log(qtx)",main="Spain-1970") 
points(log(Sq.fem[21,]),type="l",col="red") 
points(log(PSq.fem[21,]),type="l",col="green") 
plot(log(Sr$V1),xlab="age",ylab="log(qtx)",main="Spain-2005") 
points(log(Sq.fem[56,]),type="l",col="red") 
points(log(PSq.fem[56,]),type="l",col="green") 
 
#ITALY 
plot(log(Iw$V1),xlab="age",ylab="log(qtx)",main="Italy-1970") 
points(log(Iq.fem[21,]),type="l",col="red") 
points(log(PIq.fem[21,]),type="l",col="green") 
plot(log(Ir$V1),xlab="age",ylab="log(qtx)",main="Italy-2004") 
points(log(Iq.fem[55,]),type="l",col="red") 
points(log(PIq.fem[55,]),type="l",col="green") 
 
par(mfcol=c(2,3)) 
#ENGLAND&WALES 
plot(log(EWw$V1),xlab="age",ylab="log(qtx)",main="England&Wales-1970") 
points(log(EWq.fem[21,]),type="l",col="red") 
points(log(PEWq.fem[21,]),type="l",col="green") 
plot(log(EWr$V1),xlab="age",ylab="log(qtx)",main="England&Wales-2003") 
points(log(EWq.fem[54,]),type="l",col="red") 
points(log(PEWq.fem[54,]),type="l",col="green") 
 
#WEST GERMANY 
plot(log(w$V1),xlab="age",ylab="log(qtx)",main="West Germany-1976") 
points(log(q.fem[21,]),type="l",col="red") 
points(log(Pq.fem[21,]),type="l",col="green") 
plot(log(r$V1),xlab="age",ylab="log(qtx)",main="West Germany-2004") 
points(log(q.fem[49,]),type="l",col="red") 
points(log(Pq.fem[49,]),type="l",col="green") 
 
#RUSSIA 
plot(log(Rw$V1),xlab="age",ylab="log(qtx)",main="Russia-1974") 
points(log(Rq.fem[16,]),type="l",col="red") 
points(log(PRq.fem[16,]),type="l",col="green") 
plot(log(Rr$V1),xlab="age",ylab="log(qtx)",main="Russia-2006") 
points(log(Rq.fem[48,]),type="l",col="red") 
points(log(PRq.fem[48,]),type="l",col="green") 
 
#Mortality curves for Europe 
par(mfrow=c(2,3)) 
matplot(bind2[1:90,],type="l",ylab="Death 
probability",xlab="Age",lty=1,main="West Germany") 
matplot(bind3[1:90,],type="l",ylab="Death 
probability",xlab="Age",lty=1,main="Spain") 
matplot(bind4[1:90,],type="l",ylab="Death 
probability",xlab="Age",lty=1,main="Russia") 
matplot(bind5[1:90,],type="l",ylab="Death 
probability",xlab="Age",lty=1,main="Italy") 
matplot(bind6[1:90,],type="l",ylab="Death 
probability",xlab="Age",lty=1,main="France") 
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matplot(bind7[1:90,],type="l",ylab="Death 
probability",xlab="Age",lty=1,main="England&Wales") 
 
 
#PERKS 
#Estimation 
Pfem=read.table("perksEGfemale.txt") 
par(mfrow=c(2,1)) 
year=array(seq(1956,2004,by=1),c(1,49)) 
plot(year,-Pfem[,2],xlab="Year, t",ylab="A-1(t)",type="o") 
plot(year,Pfem[,3],xlab="Year, t",ylab="A-2(t)",type="o") 
 
#Finding death probability 
a=111 
Pq.fem=matrix(NA,49,a) 
 
qkx=function(k,x,sex) 
{ 
 exp(-sex[k,2]+((x+1)*sex[k,3]))/(1+exp(-sex[k,2]+((x+1)*sex[k,3]))) 
} 
 
for(i in 1:49) 
{ 
 for(age in 0:(a-1)) 
 { 
  Pq.fem[i,age+1]=qkx(i,age,Pfem) 
  
 } 
}  
 
R=cbind(Pq.fem[1,],Pq.fem[21,],Pq.fem[41,],Pq.fem[49,]) 
#par(mfrow=c(2,1)) 
matplot(R[,1:4],type ="l", xlab="Age", ylab="Death 
probability",main="Female estimated data",lty=1) 
cols = c("black","red","green","blue") 
legend("topleft",c("1956","1976","1996","2004"),fill=cols) 
 
#Forecasting 
#Female 
#Estimation 
Pfem=read.table("perksEGfemale.txt") 
 
#Finding mu 
PFmu1=mean(diff(-Pfem[,2])) 
PFmu2=mean(diff(Pfem[,3])) 
 
 
#Finding A1 and A2 
y=46 
PFa1=array(NA,y+1) 
PFa1[1]=-Pfem[49,2] 
PFa2=array(NA,y+1) 
PFa2[1]=Pfem[49,3] 
 
Pa1=diff(-Pfem$V2) 
Pb1=diff(Pfem$V3) 
Pc1=cbind(Pa1,Pb1) 
PcovF=cov(Pc1) 
Pmean=c(0,0) 
 
Ef=array(NA,c(1000,2)) 
for(i in 1:y) 
{ 
 for(a in 1:1000) 
 { 
  Ef[a,]=rmvnorm(1,Pmean,PcovF) 
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 } 
 Ef1=mean(Ef[,1]) 
 Ef2=mean(Ef[,2]) 
 PFa1[i+1]=PFmu1+PFa1[i]+Ef1 
 PFa2[i+1]=PFmu2+PFa2[i]+Ef2 
} 
 
PFa=cbind(PFa1,PFa2) 
 
 
#Finding death probability 
a=111 
Pq.fem=matrix(NA,y,a) 
 
qkx=function(k,x,sex) 
{ 
 exp(sex[k,1]+((x+1)*sex[k,2]))/(1+exp(sex[k,1]+((x+1)*sex[k,2]))) 
} 
 
for(i in 1:y) 
{ 
 for(age in 0:(a-1)) 
 { 
  Pq.fem[i,age+1]=qkx(i,age,PFa) 
  
 } 
} 
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